News

Bio-Rad Introduces Pioneer Antibody Discovery Platform for Therapeutic Development

November 22, 2022

The Pioneer Antibody Discovery Platform is a new antibody discovery service specifically designed to develop best-in-class biologic candidates.

FDA Approves Injection Designed to Delay Onset of Type 1 Diabetes

November 21, 2022

Tzield (teplizumab-mzwv) injection is the first FDA-approved therapy designed to delay the onset of stage 3 type 1 diabetes in adults and pediatric patients 8 years and older.

FDA Committee Recommends Ardelyx Kidney Disease Drug

November 21, 2022

Initially rejected in July 2021, XPHOZAH (tenapanor) won recommendations as both a monotherapy and combination treatment from FDA’s CRDAC meeting.

Biotech Startup Raises $5.4M to Develop AI-Designed Protein Machines and Cell Factories

November 21, 2022

Biotech startup, Cradle, has raised $5.4 million in seed funding with an AI-enabled design platform that allows for the synthetic building of cell factories to produce proteins.

Element’s New Air Treatment Testing Facility Supports Indoor Space Public Health Air Quality

November 21, 2022

Element has opened a new 7500-ft3 facility that will be used to evaluate aerosolized product efficacy for reducing airborne organisms and viral particles.

CellVax and Theragent Form Manufacturing Pact for Novel Cancer Immunotherapy Drug Candidate

November 17, 2022

CellVax Therapeutics has selected Theragent, a new CDMO, to manufacture clinical trial material for a new Phase II prostate cancer immunotherapy drug candidate.

Sanofi and Insilico Medicine Ink $1.2 Billion Drug Development Deal

November 16, 2022

The deal will see Sanofi use Insilico’s AI drug discovery platform to advance up to six new drug development candidates.

Indivior Acquires Opiant for $145 Million

November 16, 2022

Indivior’s acquisition of Opiant grants them access to the company’s portfolio of investigational opioid overdose reversal agent, OPNT003.

ReiThera Expands Viral Vector Production Capabilities with Opening of New Manufacturing Facility

November 14, 2022

The new facility will allow ReiThera to consolidate its competitive position as a leading CDMO specialized in viral vector production.

Avantor Opens New Distribution Center in Dublin, Ireland

November 14, 2022

Avantor is continuing its investment to support the biopharma market with the opening of its new distribution center in Dublin, Ireland.